The antibody was isolated from a human scFv phage display library, indicating that the cloning process involved the selection of specific single-chain variable fragments (scFvs) that exhibit high affinity for the WT1/HLA-A2 complex.
This product is a high-affinity TCR-like antibody suitable for the treatment of WT1-positive tumors. Due to its specificity and potency against tumor target cells, it may have potential for cancer immunotherapy.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for VS-0125-FY101. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.